Mast cells as "tunable" effector and immunoregulatory cells: Recent advances

被引:1011
作者
Galli, SJ [1 ]
Kalesnikoff, J [1 ]
Grimbaldeston, MA [1 ]
Piliponsky, AM [1 ]
Williams, CMM [1 ]
Tsai, M [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
关键词
acquired immunity; allergy; basophils; cytokines; inflammation; innate immunity; signaling; tissue remodeling;
D O I
10.1146/annurev.immunol.21.120601.141025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on recent progress in our understanding of how mast cells can contribute to the initiation, development, expression, and regulation of acquired immune responses, both those associated with IgE and those that are apparently expressed independently of this class of Ig. We emphasize findings derived from in vivo studies in mice, particularly those employing genetic approaches to influence mast cell numbers and/or to alter or delete components of pathways that can regulate mast cell development, signaling, or function. We advance the hypothesis that mast cells not only can function as proinflammatory effector cells and drivers of tissue remodeling in established acquired immune responses, but also may contribute to the initiation and regulation of such responses. That is, we propose that mast cells can also function as immunoregulatory cells. Finally, we show that the notion that mast cells have primarily two functional configurations, off (or resting) or on (or activated for extensive mediator release), markedly oversimplifies reality. Instead, we propose that mast cells are "tunable," by both genetic and environmental factors, such that, depending on the circumstances, the cell can be positioned phenotypically to express a wide spectrum of variation in the types, kinetics, and/or magnitude of its secretory functions.
引用
收藏
页码:749 / 786
页数:38
相关论文
共 205 条
[2]   Dok protein family members are involved in signaling mediated by the type 1 Fcε receptor [J].
Abramson, J ;
Rozenblum, G ;
Pecht, I .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (01) :85-91
[3]  
ALAM R, 1994, J IMMUNOL, V152, P1298
[4]   THE INTESTINAL MAST-CELL RESPONSE TO TRICHINELLA-SPIRALIS INFECTION IN MAST CELL-DEFICIENT W/WV MICE [J].
ALIZADEH, H ;
MURRELL, KD .
JOURNAL OF PARASITOLOGY, 1984, 70 (05) :767-773
[5]  
ARIZONO N, 1993, BLOOD, V81, P2572
[6]   Regulation of mast cell survival by IgE [J].
Asai, K ;
Kitaura, J ;
Kawakami, Y ;
Yamagata, N ;
Tsai, M ;
Carbone, DP ;
Liu, FT ;
Galli, SJ ;
Kawakami, T .
IMMUNITY, 2001, 14 (06) :791-800
[7]  
ASKENASE PW, 1983, J IMMUNOL, V131, P2687
[8]   Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion [J].
Bandeira-Melo, C ;
Woods, LJ ;
Phoofolo, M ;
Weller, PF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :841-850
[9]   Human mast cells release metalloproteinase-9 on contact with activated T cells:: Juxtacrine regulation by TNF-α [J].
Baram, D ;
Vaday, GG ;
Salamon, P ;
Drucker, I ;
Hershkoviz, R ;
Mekori, YA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :4008-4016
[10]   Mast cells in autoimmune disease [J].
Benoist, C ;
Mathis, D .
NATURE, 2002, 420 (6917) :875-878